{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:23:38Z","timestamp":1759483418993},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1989,7,1]],"date-time":"1989-07-01T00:00:00Z","timestamp":615254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[1989,7]]},"DOI":"10.1378\/chest.96.1.216","type":"journal-article","created":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T18:25:26Z","timestamp":1194459926000},"page":"216-218","source":"Crossref","is-referenced-by-count":7,"title":["Gold-Naproxen Pneumonitis"],"prefix":"10.1016","volume":"96","author":[{"given":"Robin G.","family":"McFadden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence J.","family":"Fraher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.96.1.216_bib1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJM197604222941703","article-title":"Diffuse pulmonary injury associated with gold treatment.","volume":"294","author":"Winterbauer","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.96.1.216_bib2","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1136\/bmj.1.6023.1444","article-title":"Pulmonary fibrosis associated with hypersensitivity to gold salts.","volume":"1","author":"Geddes","year":"1976","journal-title":"Br Med J"},{"key":"10.1378\/chest.96.1.216_bib3","first-page":"145","article-title":"Pneumonitis caused by gold salt therapy: evidence for the role of cell-mediated immunity in its pathogenesis.","volume":"122","author":"McCormick","year":"1980","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.96.1.216_bib4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/0002-9343(81)90397-1","article-title":"Reversal of progressive, life-threatening gold hypersensitivity pneumonitis by corticosteroids.","volume":"71","author":"Levinson","year":"1981","journal-title":"Am J Med"},{"key":"10.1378\/chest.96.1.216_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jama.1980.03310030045026","article-title":"Life-threatening hypersensitivity to sulindac.","volume":"244","author":"Smith","year":"1980","journal-title":"JAMA"},{"key":"10.1378\/chest.96.1.216_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00007611-198102000-00032","article-title":"Ibuprofen hypersensitivity in systemic lupus erythematosus.","volume":"74","author":"Ruppert","year":"1981","journal-title":"South Med J"},{"key":"10.1378\/chest.96.1.216_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7326\/0003-4819-95-2-245_1","article-title":"Sulindac and pneumonitis (letter).","volume":"95","author":"Fein","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.96.1.216_bib8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1378\/chest.83.2.280","article-title":"Pulmonary infiltrates with eosinophilia due to naproxen.","volume":"83","author":"Nader","year":"1983","journal-title":"Chest"},{"key":"10.1378\/chest.96.1.216_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.1984.03340250045019","article-title":"Pulmonary infiltrates associated with naproxen.","volume":"251","author":"Buscaglia","year":"1984","journal-title":"JAMA"},{"key":"10.1378\/chest.96.1.216_bib10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(67)91362-1","article-title":"Lymphocyte transformation in drug hypersensitivity.","volume":"1","author":"Sarkany","year":"1967","journal-title":"Lancet"},{"key":"10.1378\/chest.96.1.216_bib11","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/ard.27.6.582","article-title":"The lymphocyte transformation test and gold hypersensitivity.","volume":"27","author":"Denman","year":"1968","journal-title":"Ann Rheum Dis"},{"key":"10.1378\/chest.96.1.216_bib12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/bmj.3.5882.676","article-title":"Immunological studies on the mechanism of gold hypersensitivity reactions.","volume":"2","author":"Davis","year":"1973","journal-title":"Br Med J"},{"key":"10.1378\/chest.96.1.216_bib13","first-page":"1089","article-title":"Lymphocyte transformation studies in drug hypersensitivity.","volume":"120","author":"Warrington","year":"1979","journal-title":"Can Med Assoc J"},{"key":"10.1378\/chest.96.1.216_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/ard.32.4.301","article-title":"Effects of gold salts and prednisolone on inflammatory cells: II. Suppression of inflammation and phagocytosis in the rat.","volume":"32","author":"Vernon-Roberts","year":"1973","journal-title":"Ann Rheum Dis"},{"key":"10.1378\/chest.96.1.216_bib15","first-page":"357","article-title":"Effects of a gold salt on lymphocyte responses.","volume":"27","author":"Harth","year":"1977","journal-title":"Clin Exp Immunol"},{"key":"10.1378\/chest.96.1.216_bib16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1172\/JCI108660","article-title":"Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds.","volume":"59","author":"Lipsky","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.96.1.216_bib17","first-page":"490","article-title":"Modulation of macrophage-lymphocyte interactions by the antiarthritic gold compound, auranofin.","volume":"12","author":"Griswold","year":"1985","journal-title":"J Rheumatol"},{"issue":"supplement 4B","key":"10.1378\/chest.96.1.216_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0002-9343(84)80086-8","article-title":"Immunologic effects of nonsteroidal anti-inflammatory drugs.","volume":"77","author":"Goodwin","year":"1984","journal-title":"Am J Med"},{"issue":"supplement 4B","key":"10.1378\/chest.96.1.216_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9343(84)80088-1","article-title":"Nonsteroidal anti-inflammatory drugs and immunologic function: overview of the European experience.","volume":"77","author":"Bacon","year":"1984","journal-title":"Am J Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215457794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215457794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T03:50:10Z","timestamp":1546487410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215457794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,7]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1989,7]]}},"alternative-id":["S0012369215457794"],"URL":"https:\/\/doi.org\/10.1378\/chest.96.1.216","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1989,7]]}}}